CDH Baifu
Professional Boutique Fund Focusing on Technology

30

IPOs

150+

Portfolio

$110bn

AUM
Focus on Technology Investment, Create Professional Boutique Funds

CDH BAIFU, founded in 2012, is a professional boutique fund investment platform focusing on technology under CDH Investments. We carry out investments with strategies centering on new trends, novel regions, and counter-cyclical targets. We systematically focus on specific technology driven industries, including semiconductors, high-end equipment, biomedicine, artificial intelligence, technology overseas and more. As of 2022, CDH BAIFU has completed  over 100 investments and reached over 70 billion RMB under management.

Uncover and unlock industry value, Provide Diversified Asset management services
CDH BAIFU believes in research-driven investing strategy. By uncovering value on individual portfolios, establishing unique portfolio matrixes, and promoting their mutual cooperation, we build up deep industry insights and develop solid sourcing channels. CHD BAIFU offers alternative asset management products ,including equity, quasi-fixed income, real estate investment and more. Through the innovative dedicated investment account, we diversify our asset allocation to meet both return and liquidity requirement of different investors.
Maintain the Spirit of Diligence, Approach to long-term value investing

CDH BAIFU always maintains the spirit of diligence and approach to long-term value investing. We also effectively empower the portfolio companies and actively reinforce the post-investment management. With years of management experience in business strategy, finance, andhuman resources, we form a complete set of practice-tested management toolkits to  add value on our portfolios and always dedicate for mutual benefits and growth

Our Portfolio
CDH Baifu has three areas of focus: Next-generation of information technology, High-end equipment, Biological Technology
Next-generation of information technology
Next-generation of information technology
Learn More
Biological Technology
Biological Technology
Learn More
High-end equipment
High-end equipment
Learn More
Case Studies
  • Invested in 2015
    CDH WM helps Loongson go forward in the journey of independent innovation

    June 2015, CDH WM has invested many times in Loongson, a leading domestic CPU company. The core team of Loongson originated from the Institute of Computer Science, Chinese Academy of Sciences. Under the leadership of the founder, Mr. Hu Weiwu, it has developed independently since 2001. After 20 years of unremitting efforts, Loongson insists on independent innovation, fully masters the core computer technologies such as CPU instruction system, processor IP core, operating system, etc., and creates an independent and open software and hardware ecology and information industry system. Its technology has reached the top level in China and can also be compared with international advanced products. CDH WM will continue to firmly support Loongson to take LoongArch as an opportunity to create a core chapter for the safe development of independent systems, in-depth layout of industrial chain supporting and application ecology, adhere to the construction of a national independent information system , and be a strong foundation for the country's innovative business! Loongson has also been approved by the Shanghai Stock Exchange and the China Securities Regulatory Commission for listing, and will be listed on the Science and Technology Innovation Board in June 2022 to complete the IPO.

  • Invested in 2016
    Successfully replicating the experience of Didi investment project in China, CDH invests in Grab, the largest car-hailing giant in Southeast Asia

    CDH invested in Grab, an online car-hailing and food delivery platform company, in Southeast Asia in August 2016. On December 2, 2021, Grab was listed on the NASDAQ in the United States as a SPAC (stock code: Grab). Headquartered in Singapore, Grab currently operates in 428 cities in 8 countries in Southeast Asia. The company is building a "super APP", similar to WeChat or Alipay. Grab's current functions include mobile travel, ordering food or groceries, sending Packages, online payments or access to loans, insurance, wealth management, telehealth, and more.

  • Invested in 2020
    The commercial application of China's Beidou system is at the right time, and CDH WM has twice supported Beidou navigation chip companies

    CDH WM invested twice in China's Beidou navigation satellite positioning chip and solution provider, Allystar, in July 2020 and May 2021. Allystar, formerly known as Huada Electronic Navigation Division under China Electronics Corporation (CEC), was registered and established on December 6, 2016. It is a national high-tech enterprise, Shenzhen high-tech enterprise, Zhongguancun high-tech enterprisec and an enterprise Shenzhen Municipal Government focused on introducing with weak links in the industrial chain in 2016. The core team has more than 30 years of experience in chip R&D and marketization. At present, Allystar focuses on the independent design, research and development, sales and related business of navigation and positioning chips, algorithms and products, aiming at the civilian consumer electronics market and special terminal markets such as the national lifeline industry, the automotive field and IOT.

  • Invested in 2021
    A leader in the field of cell therapy, creating the first CAR-T drug independently developed in China

    CDH WM invests in Reindeer Bio, a leading company in the field of cell therapy in China, in August 2021. On June 2, 2022, the China National Medical Products Administration (NMPA) officially accepted the launch of License Application (NDA) of the CAR-T drug Iquilenza injection developed by Reindeer Bio for the treatment of relapsed/refractory multiple myeloma (R/R MM). Iquirenza injection is the first self-developed CAR-T cell therapy product in China. It is the first domestically submitted new drug to be accepted for marketing and is expected to become the first domestically approved autologous chimeric antigen teceptor T cell immunotherapy products targeting BCMA.. The product has been granted "Breakthrough Therapy Drug ( BTD)" designation by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in February 2021. The approval and marketing of Iquilenx injection will be a milestone event in the field of cell therapy in China.

01/
Investment Team
Ying Wei
Managing Partner
Baifu
Wei Bin
Senior Partner
Li Dan
Senior Partner
CDH Baifu
Professional Boutique Fund Focusing on Technology

30

IPOs

150+

Portfolio

$110bn

AUM
Overview
Focus on Technology Investment, Create Professional Boutique Funds

CDH BAIFU, founded in 2012, is a professional boutique fund investment platform focusing on technology under CDH Investments. We carry out investments with strategies centering on new trends, novel regions, and counter-cyclical targets. We systematically focus on specific technology driven industries, including semiconductors, high-end equipment, biomedicine, artificial intelligence, technology overseas and more. As of 2022, CDH BAIFU has completed  over 100 investments and reached over 70 billion RMB under management.

Uncover and unlock industry value, Provide Diversified Asset management services
CDH BAIFU believes in research-driven investing strategy. By uncovering value on individual portfolios, establishing unique portfolio matrixes, and promoting their mutual cooperation, we build up deep industry insights and develop solid sourcing channels. CHD BAIFU offers alternative asset management products ,including equity, quasi-fixed income, real estate investment and more. Through the innovative dedicated investment account, we diversify our asset allocation to meet both return and liquidity requirement of different investors.
Maintain the Spirit of Diligence, Approach to long-term value investing

CDH BAIFU always maintains the spirit of diligence and approach to long-term value investing. We also effectively empower the portfolio companies and actively reinforce the post-investment management. With years of management experience in business strategy, finance, andhuman resources, we form a complete set of practice-tested management toolkits to  add value on our portfolios and always dedicate for mutual benefits and growth

Our Portfolio
CDH Baifu has three areas of focus: Next-generation of information technology, High-end equipment, Biological Technology
Next-generation of information technology
Biological Technology
High-end equipment
Case Studies
Investment Team
Ying Wei
Managing Partner
Baifu
Wei Bin
Senior Partner
Li Dan
Senior Partner